Boston Scientific Q3 2024 10-Q Filed
Ticker: BSX · Form: 10-Q · Filed: 2024-11-01T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
BSC 10-Q filed: Q3 2024 results are in, compare to Q3 2023. Check financials.
AI Summary
Boston Scientific Corporation filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter of 2024, comparing them to the same period in 2023. Key financial data and operational segments are detailed within the filing.
Why It Matters
This filing provides investors with the official financial performance of Boston Scientific for the third quarter of 2024, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 2024-09-30 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial data is reported.)
- 2024-11-01 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2024-01-01 — Reporting Period Start Date (Indicates the beginning of the fiscal year-to-date period.)
Key Players & Entities
- Boston Scientific Corp (company) — Filer of the 10-Q
- 2024-09-30 (date) — End of the reporting period
- 2024-11-01 (date) — Filing date
- 2024-01-01 (date) — Start of the reporting period
- 2023-09-30 (date) — Comparison period end date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on November 1, 2024.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0000885725.
What is the Standard Industrial Classification (SIC) code for Boston Scientific Corp?
The SIC code for Boston Scientific Corp is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
What fiscal year end does Boston Scientific observe?
Boston Scientific observes a fiscal year end of December 31.
From the Filing
0000885725-24-000073.txt : 20241101 0000885725-24-000073.hdr.sgml : 20241101 20241101063326 ACCESSION NUMBER: 0000885725-24-000073 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 82 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241101 DATE AS OF CHANGE: 20241101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 241416945 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 10-Q 1 bsx-20240930.htm 10-Q bsx-20240930 0000885725 12/31 2024 Q3 false P1Y P2Y 280 539 280 iso4217:USD xbrli:shares xbrli:shares iso4217:USD xbrli:pure iso4217:HKD xbrli:shares utr:Rate iso4217:EUR bsx:derivative_instrument bsx:reportablesegments bsx:business 0000885725 2024-01-01 2024-09-30 0000885725 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0000885725 bsx:SeniorNotedue2027Member 2024-01-01 2024-09-30 0000885725 2024-10-29 0000885725 2024-07-01 2024-09-30 0000885725 2023-07-01 2023-09-30 0000885725 2023-01-01 2023-09-30 0000885725 2024-09-30 0000885725 2023-12-31 0000885725 us-gaap:CommonStockMember 2024-09-30 0000885725 us-gaap:PreferredStockMember 2024-06-30 0000885725 us-gaap:PreferredStockMember 2023-06-30 0000885725 us-gaap:PreferredStockMember 2023-12-31 0000885725 us-gaap:PreferredStockMember 2022-12-31 0000885725 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0000885725 us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0000885725 us-gaap:PreferredStockMember 2024-01-01 2024-09-30 0000885725 us-gaap:PreferredStockMember 2023-01-01 2023-09-30 0000885725 us-gaap:PreferredStockMember 2024-09-30 0000885725 us-gaap:PreferredStockMember 2023-09-30 0000885725 us-gaap:CommonStockMember 2024-06-30 0000885725 us-gaap:CommonStockMember 2023-06-30 0000885725 us-gaap:CommonStockMember 2023-12-31 0000885725 us-gaap:CommonStockMember 2022-12-31 0000885725 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000885725 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000885725 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0000885725 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0000885725 us-gaap:CommonStockMember 2023-09-30 0000885725 us-gaap:TreasuryStockCommonMember 2024-06-30 0000885725 us-gaap:TreasuryStockCommonMember 2023-06-30 0000885725 us-gaap:TreasuryStockCommonMember 2023-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2022-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2024-07-01 2024-09-30 0000885725 us-gaap:TreasuryStockCommonMember 2023-07-01 2023-09-30 0000885725 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-09-30 0000885725 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-09-30 0000885725 us-gaap:TreasuryStockCommonMember 2024-09-30 0000885725 us-gaap:TreasuryStockCommonMember 2023-09-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000885725 us-gaap:RetainedEarningsMember 2024-06-30 0000885725 us-gaap:RetainedEarningsMember 2023-06-30 0000885725 us-gaap:RetainedEarningsMember 2023-12-31 0000885725 us-gaap:R